European SPC Manufacturing Waiver Comes Into Effect
Timeline: Key Events For The Development Of A Waiver To Allow Manufacturing And Stockpiling For Day-One Launch
In Vivo has traced the history of the newly affirmed European SPC manufacturing waiver from early industry lobbying efforts to its ultimate entry into force. The mechanism has been met with controversy throughout its evolution.
You may also be interested in...
Perrigo has received US FDA approval for a generic version of Teva’s ProAir albuterol inhaler. The firm is immediately launching a “limited quantity” but is also ramping up production with partner Catalent to meet future demand.
Neuraxpharm has struck a deal to acquire Glenmark’s CNS portfolio in Poland. As part of the agreement, Glenmark’s Jacek Sawicki has been named as general manager of Neuraxpharm Polska and will lead a business that now incorporates Glenmark’s CNS commercial team.
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.